Revising the ICD: explaining the WHO approach

Boerma, Ties; Harrison, James Edward; Jakob, Robert; Mathers, Colin; Schmider, Anneke; Weber, Stefanie

doi:10.1016/s0140-6736(16)31851-7

Cited by 38 publications

(26 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…B. in Deutschland sehr häufige Infektionskrankheit Campylobacter-Enteritis nur als einzelner vierstelliger Code (A04.5) als sonstige bakterielle Darminfektion codiert wird, werden für die Tuberkulose, deren Inzidenz in Deutschland deutlich geringer ist, fünf verschiedene dreistellige Codes (A15-A19) verwendet. 1…”

Section: Codierung Von Infektionskrankheitenunclassified

“…Die grundlegende Umstrukturierung der ICD bietet viele Chancen, insbesondere die einer differenzierteren und korrekten Abbildung von Krankheiten. Gleichzeitig birgt die hohe Komplexität Gefahren wegen der durch sie bedingten Verzögerungen bei der Implementierung und der erschwerten Anwendbarkeit in der Praxis [1]. Dabei [24,25].…”

Section: Anforderungen Und Erwartungen An Die Icd-11unclassified

See 1 more Smart Citation

Infektionskrankheiten und ihre Codierung

Diercke

Beermann

Tolksdorf

et al. 2018

Bundesgesundheitsbl

View full text Add to dashboard Cite

The revision of the International Classification of Diseases (ICD) could change morbidity and mortality statistics significantly, which also affects the area of infectious diseases. Infectious diseases are classified according to their etiology, affected body system or the life period during which the episode occurs. Specific challenges arise from emerging pathogens and the respective necessary adaptation. For epidemiologic analysis ICD-10 does not always offer enough additional information.ICD provides the basis for international comparison of infectious disease morbidity and mortality statistics, but it is also used to collect data for surveillance and research purposes, e. g. the notification system for infectious diseases, syndromic surveillance systems and the evaluation of data quality by using secondary data sources.ICD-11 offers the chance to better represent epidemiological concepts of infectious diseases by adding more relevant information as affected body system or manifestation. Due to the complexity of coding, ensuring continuity of morbidity and mortality statistics could be challenging.

show abstract

Section: Codierung Von Infektionskrankheitenunclassified

Section: Anforderungen Und Erwartungen An Die Icd-11unclassified

Infektionskrankheiten und ihre Codierung

Diercke

Beermann

Tolksdorf

et al. 2018

Bundesgesundheitsbl

View full text Add to dashboard Cite

show abstract

“…Fibromyalgia (FM), according to the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) M79.7, including Fibromyositis, Fibrositis and Myofibrositis, is defined as a chronic disorder of unknown etiology characterized by low pain threshold, stiffness and tenderness in the muscles of neck, shoulders, back, hips, arms, and legs, usually accompanied by headaches, fatigue, sleep disturbances, memory loss and painful menstruation [1][2][3][4]. Patients present inflammation and fibrous degeneration of muscles [1].…”

Section: Introductionmentioning

confidence: 99%

“…Patients present inflammation and fibrous degeneration of muscles [1]. Similarly, Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) (ICD-10-CM R53.82 or G93.3 if post-viral) is defined as an acquired complex multisystem disease with characteristic clinical features that include exercise-induced fatigue, post-exertional malaise (PEM)/symptom exacerbation, cognitive dysfunction, orthostatic intolerance, on-going flu-like symptoms and unrefreshing sleep in conjunction with other [5,6].…”

Section: Introductionmentioning

confidence: 99%

Unraveling molecular determinants of manual therapy: an approach to integrative therapeutics for the treatment of fibromyalgia and CFS/ME

Espejo¹,

García-Escudero²,

Oltra³

2018

Preprint

View full text Add to dashboard Cite

Abstract:Application of protocols without parameter standardization and rigorous controls has led manual therapy (MT) and other physiotherapy approaches to controversial outcomes. Thus, there is an urgency to carefully define standard protocols that elevate physiotherapy treatments to rigorous scientific demands. One way this can be achieved is by studying gene expression and additional physiological changes that associate to particular, parameter-controlled, treatments in animal models and translating this knowledge to properly design objective, quantitatively-monitored clinical trials. Here, we propose a Molecular Physiotherapy Approach (MPTA), requiring multidisciplinary teams, to uncover the scientific reasons behind the numerous reports of MT that historically attribute benefits to these treatments. The review focuses in the identification of MT-induced physiological and molecular responses that could be used for the treatment of fibromyalgia (FM) and CFS/ME. The systemic effect associated to mechanical-load responses is considered of particular relevance as it suggests that defined, low-pain areas could be selected for treatments with overall benefits, an aspect that might result essential to treat FM. Additionally, MT can provide muscle conditioning to sedentary patients without demanding strenuous physical effort, detrimental for CFS/ME patients, placing MT as a real option for integrative medicine programs to treat FM and CFS/ME.

show abstract

“…7 In doing so, the World Health Organization sustained that ICD is essentially a pathogenic classification. 8 However, the clinical features of stroke are neurological and not vascular. In fact, the types and sites of damaged brain vessels are associated with distinct clinical poststroke disabilities.…”

mentioning

confidence: 99%